No Data
Is 3D Medicines (HKG:1244) Using Too Much Debt?
3D MEDICINES: Interim Report 2024
Hong Kong Stock Market Surges | Sino-Biopharmaceutical Limited (01244) fell more than 15% to a new low, with a total market value of less than 0.6 billion Hong Kong dollars. The company has been excluded from the Hong Kong Stock Connect.
Citic Pharma (01244) fell more than 15%, hitting a new low of HK$2.31 since its listing, with a current market cap of only HK$0.599 billion, evaporating more than HK$33 billion from its peak.
Sino Biopharmaceutical Limited (01244) fell 58.90%, now at 2.960 yuan, hitting a new 52-week low.
As of 11:47, Si Lu Di Pharmaceutical (01244) fell 58.90% from the previous closing price and is now trading at HKD 2.960, hitting a 52-week low. The volume of transactions was 0.3215 million shares, with a turnover of HKD 0.9347 million.
3D Medicines Executives Bolster Shareholdings
Sirtu Pharmaceuticals (01244) executive director and single largest shareholder as well as senior management increased their holdings.
SinoMab BioScience Limited (01244) announced that the board of directors of the company has recently received the company's founder, chairman, and CEO...
No Data
